CMS issues new drug rules to save $17B

The Centers for Medicare & Medicaid Services (CMS) has issued new rules expected to cut Medicaid spending on drugs by about $17.7 billion over the next five years, according to Bloomberg. The savings will be achieved primarily from shifting more costs to pharmaceutical manufacturers and pharmacies. The new rule "puts in place simple measures that will cut costs, increase transparency and benefit consumers," CMS acting administrator Marilyn Tavenner said in a press release Friday. Statement

Suggested Articles

Presidential candidate Kamala Harris wants to get rid of the tax break drug companies get for DTC ads

Healthcare software company Phreesia closed its first day of trading as a public company Thursday about 40% above its set price.

Growing the biosimilar market could lead to significant healthcare cost savings, according to a new report.